MedTrace Logo

L-Arginine and Erectile Dysfunction

NCT00777075 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 57

Last updated 2008-10-22

No results posted yet for this study

Summary

The purpose of the study is to determine whether the treatment with L-arginine leads to an improvement of erectile dysfunction in patients with erectile dysfunction.

Conditions

Interventions

DRUG

L-arginine

DRUG

Placebo

Sponsors & Collaborators

  • Pharmacia

    collaborator INDUSTRY

  • Hannover Medical School

    lead OTHER

Principal Investigators

  • Dirk O. Stichtenoth, MD · Institute of Clinical Pharmacology, Hannover Medical School

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-07-31
Completion
2005-11-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00777075 on ClinicalTrials.gov